未登录.png)
分享.png)
收藏Leveraging low-cost app-based step count data to assess depression and anxiety in university students: A cross-sectional mobile health study
Huang, Jiali; Zhang, Yuezhou; Zhou, Dongsheng; Li, Xingxing; Li, Hui; Lian, Bin; Cai, Weiming; Cao, Liyu; Liu, Juan; Xu, Fenfen; Wang, Lang; Fu, Zhengke; Han, Zhili; Qin, Shengjie; Wei, Chaoran; Fei, Zihan; Zhao, Xianghong 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Dynamic Change of PD-L2 on Circulating Plasma Extracellular Vesicles as a Predictor of Treatment Response in Melanoma Patients Receiving Anti-PD-1 Therapy循环血浆外泌体上PD-L2的动态变化作为接受抗PD-1治疗黑色素瘤患者治疗反应的预测指标Sun, Linzi; Wei, Xiaoting; Zhao, Qian; Mao, Lili; Bai, Xue; Li, Caili; Gu, Junjie; Kong, Yan; Cui, Chuanliang; Chi, Zhihong; Sheng, Xinan; Lian, Bin; Wang, Xuan; Li, Siming; Yan, Xieqiao; Tang, Bixia; Zhou, Li; Li, Juan; Guo, Jun; Si, Lu; Dai, Jie 分享 收藏 分享 收藏 分享 收藏 Mucin 18-targeted humanized monoclonal antibody immune positron emission tomography imaging and patient-derived tumor xenograft visualization粘蛋白18靶向人源化单克隆抗体免疫正电子发射断层显像和患者来源的肿瘤异种移植可视化Zhang, Qian; Du, Haizhen; Ma, Xiuli; Liu, Song; Kong, Xiangxing; Hu, Muye; Shi, Jing; Tang, Yanfang; Liu, Shuhui; Meng, Xun; Guo, Qian; Kong, Yan; Guo, Jun; Lian, Bin; Yang, Zhi; Zhu, Hua 分享 收藏 Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutationsBRAF突变实体瘤的诊断与治疗专家共识Wang, Wenxian; Lian, Bin; Xu, Chunwei; Wang, Qian; Li, Ziming; Zheng, Nan; Liu, Aijun; Yu, Jinpu; Zhong, Wenzhao; Wang, Zhijie; Zhang, Yongchang; Liu, Jingjing; Zhang, Shirong; Cai, Xiuyu; Liu, Anwen; Li, Wen; Mao, Lili; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Chen, Yu; Yuan, Jingping; Wang, Feng; Jiang, Zhansheng; Lin, Gen; Huang, Long; Pu, Xingxiang; Lin, Rongbo; Rao, Chuangzhou; Lv, Dongqing; Yu, Zongyang; Li, Xiaoyan; Tang, Chuanhao; Zhou, Chengzhi; Zhang, Junping; Xue, Junli; Guo, Hui; Chu, Qian; Liu, Xuewen; Wu, Jingxun; Zhang, Rui; Zhou, Jin; Zhu, Zhengfei; Li, Yongheng; Qiu, Hong; Xia, Fan; Lu, Yuanyuan; Chen, Xiaofeng; Feng, Jian; Ge, Rui; Dai, Enyong; Pan, Weiwei; Pang, Fei; Huang, Xin; Hu, Meizhen; Hao, Qing; Wang, Kai; Wu, Fan; Song, Binbin; Xu, Bingwei; Wang, Liping; Zhu, Youcai; Lin, Li; Xie, Yanru; Lin, Xinqing; Cai, Jing; Xu, Ling; Li, Jisheng; Jiao, Xiaodong; Li, Kainan; Wei, Jia; Feng, Huijing; Wang, Lin; Du, Yingying; Yao, Wang; Shi, Xuefei; Niu, Xiaomin; Yuan, Dongmei; Yao, Yanwen; Huang, Jianhui; Feng, Yue; Zhang, Yinbin; Sun, Pingli; Wang, Hong; Ye, Mingxiang; Wang, Dong; Wang, Zhaofeng; Hao, Yue; Wang, Zhen; Wan, Bin; Lv, Donglai; Yang, Shengjie; Kang, Jin; Zhang, Jiatao; Zhang, Chao; Li, Wenfeng; Fu, Jianfei; Wu, Lizhi; Lan, Shijie; Ou, Juanjuan; Shi, Lin; Zhai, Zhanqiang; Wang, Yina; Li, Bihui; Zhang, Zhang; Wang, Ke; Ma, Xuelei; Li, Zhongwu; Liu, Zhefeng; Yang, Nong; Wu, Lin; Wang, Huijuan; Jin, Gu; Wang, Guansong; Wang, Jiandong; Fang, Meiyu; Fang, Yong; Li, Yuan; Wang, Xiaojia; Chen, Jing; Zhang, Yiping; Zhu, Xixu; Shen, Yi; Ma, Shenglin; Wang, Biyun; Song, Yong; Song, Zhengbo; Si, Lu 分享 收藏 分享 收藏 Efficacy and Safety of Postoperative Adjuvant Radiation Therapy in Resected Nasal Cavity and Paranasal Sinus Mucosal Melanoma: A Combined AnalysisLian, Bin; Yang, Yue; Zheng, Baomin; Si, Lu; Zhou, Li; Chi, Zhihong; Mao, Lili; Wang, Xuan; Li, Siming; Li, Juan; Wang, Liping; Guo, Jun; Cui, Chuanliang 分享 收藏 MRG002-HER2 ADC combined with pucotenlimab (a PD-1 inhibitor), in patients with locally advanced or metastatic urothelial carcinoma (UC): Preliminary results of a phase I/II studyMRG002-HER2 ADC与pucotenlimab（一种PD-1抑制剂）联合治疗局部晚期或转移性尿路上皮癌（UC）患者的I/II期研究初步结果Cui, C.; Zhou, L.; Yang, Y.; Qu, W.; Sheng, X.; Chi, Z.; Si, L.; Mao, L.; Lian, B.; Wang, X.; Yan, X.; Li, S.; Li, C.; Wei, X.; Li, J.; Duan, R.; Xu, H.; Zhou, A.; Guo, J. 分享 收藏 Disitamab vedotin (DV) plus toripalimab (T) in unresectable locally advanced or metastatic urothelial carcinoma (la/mUC): Long-term outcomes from a phase Ib/II studyDisitamab vedotin (DV) 联合 toripalimab (T) 治疗不可切除局部晚期或转移性尿路上皮癌 (la/mUC) 的长期疗效：一项 Ib/II 期研究的结果Zhou, L.; Yang, K.; Zhang, S.; Yan, X.; Li, S.; Xu, H.; Li, J.; Chi, Z.; Mao, L.; Lian, B.; Bixia, T.; Wang, X.; Guo, H.; He, Z.; Guo, J.; Sheng, X. 分享 收藏 IBI310 (anti-CTLA-4 antibody) monotherapy or in combination with sintilimab in advanced melanoma or urothelial carcinomaCui, Chuanliang; Li, Juan; Yang, Yue; Si, Lu; Chi, Zhihong; Mao, Lili; Wang, Xuan; Tang, Bixia; Yan, Xieqiao; Li, Siming; Zhou, Li; Wei, Xiaoting; Shen, Yuping; Guo, Qun; Zheng, Shirui; Guo, Jun; Lian, Bin 分享 收藏 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
